PDS Biotechnology CorporationPDSBNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank50
3Y CAGR-13.9%
5Y CAGR+27.9%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-13.9%/yr
vs -7.2%/yr prior
5Y CAGR
+27.9%/yr
Recent deceleration
Acceleration
-6.6pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
3.4x
Strong expansion
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $41.69M | -26.3% |
| 2023 | $56.56M | -23.4% |
| 2022 | $73.82M | +13.1% |
| 2021 | $65.24M | +126.2% |
| 2020 | $28.84M | +137.1% |
| 2019 | $12.16M | -64.9% |
| 2018 | $34.65M | -60.7% |
| 2017 | $88.07M | -17.2% |
| 2016 | $106.40M | -18.3% |
| 2015 | $130.19M | - |